Abstract Body

Background: The Human APOBEC3 (A3) locus is a family of seven antiviral proteins on chromosome 22. Unlike A3D, A3F, A3G, and A3H, human A3C has little to no activity against HIV-1. However, we have previously found that for A3D and A3H, the homolog from other primates more potently blocks lentiviruses than the human version of these genes. Therefore, we hypothesized that A3C may potently restrict lentiviruses in non-human primates. To test this, we cloned A3Cs from several species and assayed for lentivirus restriction, and also performed evolutionary analyses to look for evidence of a virus-host arms race involving A3C.

Methods: We obtained A3C sequences from 12 primate species, and used the PAML software suite to perfom evolutionary analyses . Five of the A3C genes were cloned into expression vectors and their antiviral activity and sensitivity to Vif were functionally characterized. Antiviral activity was assessed by infectivity assays performed with HIV-1 and SIVagm in the absence of the viral antagonist, Vif. Sensitivity to Vif antagonism was assessed using infectivity assays with HIV-1 proviruses encoding Vifs from diverse lentiviruses. Cells were co-transfected with a provirus and each A3C or a vector control, and virions were harvested and used for infection. Virion and A3C protein expression were analyzed by Elisa and Western blot.

Results: A3Cs were functionally assayed for antiviral activity, and we found that in striking contrast to human A3C, several non-human primate A3Cs potently block HIV-1 and SIVagm (Vif deleted). In support of A3C being an active restriction factor, we found that A3C is evolving under positive selection. Futhermore, we identified rapidly evolving residues within A3:Vif binding domains, suggesting that activity against lentiviruses may drive the evolution of primate A3Cs. Preliminary evidence indicates that primate A3Cs have differential sensitivity to Vif antagonism.

Conclusions: Our functional and evolutionary data suggest that A3C is in genetic conflict with lentiviruses. The potent anti-lentiviral activity of several primate A3Cs, as well as the rapid evolution of residues important for Vif binding, indicate that A3C may play an important role in protecting primates from lentiviruses, but that human A3C has lost this activity. Thus, humans have lost the activity of an APOBEC3 antiviral gene that is present in other primates. We speculate that this lack of activity could impact our susceptibility to cross-species viral transmissions.